CoChat

The costs of drug abuse consequences: A summary of research findings

Open access
French, Michael T., Martin, Robert F. · 1996 · Journal of Substance Abuse Treatment
Cited by 58

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The purpose of this article is to provide researchers, clinicians, and policymakers with a common source of published cost estimates for drug abuse consequences. Across the broad range of potential complications associated with drug abuse, some of the cost elements are specific and directly related to drug abuse per se (e.g., drug treatment costs), while other items may be related to drug abuse (e.g., typical emergency room cost). The results presented here are based on a review of completed and ongoing studies, which include published papers, monographs, conference presentations, working papers, reports, insurance company records, newsletters, and expert judgment. Whenever possible, we report an average cost estimate and the range of available estimates. Each cost element is normalized to 1994 dollars. The results are organized by type of cost and are presented in tabular format so that the findings can be easily understood and used.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0740-5472(96)00128-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 39

  1. Administration for Families and Children, 1993, Streamlined state plan for AFDC, AFC report AFC-1346
  2. Albers, 1993, Children in foster care: Possible factors affecting permanency planning, Child and Adolescent Social Work Journal, 10, 329, 10.1007/BF00758263 · doi:10.1007/bf00758263
  3. Anderson, 1992, A sober look at the costs of intoxication, Contemporary Policy Issues, 10, 111, 10.1111/j.1465-7287.1992.tb00230.x · doi:10.1111/j.1465-7287.1992.tb00230.x
  4. Andrulis, 1995, U.S. hospital care for HIV-infected persons and the role of public and private teaching hospitals: 1988–1991, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9, 193
  5. Arno, 1989, Economic and policy implications of early intervention in HIV disease, Journal of the American Medical Association, 262, 1493, 10.1001/jama.1989.03430110083033 · DOI
  6. Avruch, 1995, Savings achieved by giving WIC benefits to women prenatally, Public Health Reports, 110, 27
  7. Benedict, 1991, Factors associated with foster care length to stay, Child Welfare, 70, 45
  8. Bennett, 1992, Medical care costs of intravenous drug users with AIDS in Brooklyn, Journal of Acquired Immune Deficiency Syndromes, 5, 1
  9. Bleichrodt, 1995, QALYs and HYEs: Under what conditions are they equivalent?, Journal of Health Economics, 14, 17, 10.1016/0167-6296(94)00033-Z · DOI
  10. Bozzette, 1994, A cost analysis of approved antiretroviral strategies in persons with advanced human immunodeficiency virus disease and zidovudine intolerance, Journal of Acquired Immune Deficiency Syndromes, 7, 355
  11. Chaikind, 1993, What do we know about the costs of special education? A selected review, The Journal of Special Education, 26, 344, 10.1177/002246699302600402 · doi:10.1177/002246699302600402
  12. Coleman, 1993, Overview of substance abuse, Primary Care, 20, 1, 10.1016/S0095-4543(21)00361-4 · DOI
  13. Conviser, 1991, A hospital-based case management program for PWAs in New Jersey, AIDS and Public Policy Journal, 6, 148
  14. French, 1995, Economic evaluation of drug abuse treatment programs: Methodology and findings, American Journal of Drug and Alcohol Abuse, 21, 111, 10.3109/00952999509095233 · DOI · Paper page
  15. French, 1996, Health care reforms and managed care for substance abuse services: Findings from eleven case studies, Journal of Public Health Policy, 17, 181, 10.2307/3342697 · DOI
  16. French, 1996, Estimating the dollar value of health outcomes from drug abuse interventions, Medical Care, 34, 890, 10.1097/00005650-199609000-00003 · DOI · Paper page
  17. French, 1995, A methodology for evaluating the costs and benefits of employee assistance programs, Journal of Drug Issues, 25, 451, 10.1177/002204269502500213 · DOI
  18. Grannemann, 1986, Estimating hospital costs: A multiple-output analysis, Journal of Health Economics, 5, 107, 10.1016/0167-6296(86)90001-9 · DOI · Paper page
  19. Heien, 1989, The economic costs of alcohol abuse: An assessment of current methods and estimates, Journal of Studies on Alcohol, 50, 567, 10.15288/jsa.1989.50.567 · DOI
  20. Hellinger, 1993, The lifetime cost of treating a person with HIV, Journal of the American Medical Association, 270, 474, 10.1001/jama.1993.03510040078033 · DOI · Paper page
  21. Hellinger, 1994, AIDS treatment costs during the last months of life: Evidence from the ACSUS, Health Services Research, 29, 569
  22. Holtgrave, 1995, Threshhold analysis and HIV prevention programs, Medical Decision Making, 15, 311, 10.1177/0272989X9501500402 · DOI
  23. Hsia, 1995, Pediatric human immunodeficiency virus infection: Recent evidence on the utilization and costs of health services, Archives of Pediatric and Adolescent Medicine, 149, 489, 10.1001/archpedi.1995.02170180019003 · doi:10.1001/archpedi.1995.02170180019003
  24. Hu, 1981, The application of cost-effectiveness analysis to the evaluation of drug abuse prevention programs: An illustration, Journal of Drug Issues, 11, 125, 10.1177/002204268101100108 · DOI
  25. Jacobs, 1995, AIDS in correctional facilities: Current status of legal issues critical to policy development, Journal of Criminal Justice, 23, 209, 10.1016/0047-2352(95)00011-E · doi:10.1016/0047-2352(95)00011-e
  26. Joyce, 1995, The impact of prenatal exposure to cocaine on newborn cost and length of stay, Health Services Research, 30, 341
  27. Lessard, 1985, Costs and benefits of chemical dependency treatment, Minnesota Medicine, 68, 449
  28. Long, 1994, The costs and financing of perinatal care in the United States, American Journal of Public Health, 84, 1473, 10.2105/AJPH.84.9.1473 · doi:10.2105/ajph.84.9.1473
  29. Mann, 1994, Can meta-analysis make policy?, Science, 266, 960, 10.1126/science.7973676 · DOI
  30. McCormick, 1985, The contribution of low birth weight to infant mortality and childhood morbidity, The New England Journal of Medicine, 312, 82, 10.1056/NEJM198501103120204 · DOI · Paper page
  31. Miller, 1993, Data watch: Victim costs of violent crime and resulting injuries, Health Affairs, 12, 186, 10.1377/hlthaff.12.4.186 · DOI · Paper page
  32. Phibbs, 1991, The neonatal costs of maternal cocaine use, Journal of the American Medical Association, 266, 1521, 10.1001/jama.1991.03470110067035 · DOI · Paper page
  33. Pitts, 1990, Variation in the THC content in illicitly imported cannabis products—1984–1989, Journal of Pharmacy and Pharmacology, 42, 817, 10.1111/j.2042-7158.1990.tb07032.x · doi:10.1111/j.2042-7158.1990.tb07032.x
  34. Raddiee, 1990, Hospital cost analysis for Nevada, Nevada Review of Business & Economics, 15, 2
  35. Rajkumar, A.S., & French, M.T. (in press). Drug abuse, crime costs, and the economic benefits of treatment. Journal of Quantitative Criminology.
  36. Reis, 1991, Costs and benefits of deferred teenage births, Evaluation and Program Planning, 14, 63, 10.1016/0149-7189(91)90040-N · doi:10.1016/0149-7189(91)90040-n
  37. Schwartz, 1989, What price prematurity?, Family Planning Perspectives, 21, 170, 10.2307/2135808 · DOI
  38. Van Stelle, 1994, Recidivism to the criminal justice system of substance-abusing offenders diverted into treatment, Crime and Delinquency, 40, 175, 10.1177/0011128794040002003 · DOI
  39. Zarkin, 1994, A conceptual framework for the economic evaluation of substance abuse interventions, Evaluation and Program Planning, 17, 409, 10.1016/0149-7189(94)90041-8 · DOI

Cited by

See all 58

Metadata

Authors
French, M. T., & Martin, R. F.
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
1996-11
Volume
13
Issue
6
Pages
453-466
ISSN
0740-5472 (ISSN-L)
OpenAlex
W2136621518
Cited by
58
References
2
FWCI
2.67
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The costs of drug abuse consequences: A summary of research findings. https://app.cochat.ai/papers/10.1016/s0740-5472(96)00128-6
The paper
French, M. T., & Martin, R. F. (1996). The costs of drug abuse consequences: A summary of research findings. Journal of Substance Abuse Treatment. https://doi.org/10.1016/s0740-5472(96)00128-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.